Toshiya Takahashi

Dr. Toshiya Takahashi

Department of Dermatology, Tohoku University Graduate School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Toshiya TakahashiToshiya Takahashi
Toshiya Takahashi
KYKenshi Yamasaki
Kenshi Yamasaki
Psoriasis is a systemic inflammatory disease caused by crosstalk between various cells such as T cells, neutrophils, dendritic cells, and keratinocytes. Antimicrobial peptides (AMPs) such as β-defensin, S100, and cathelicidin are secreted from these cells and activate the innate immune system through various mechanisms to induce inflammation, thus participating in the pathogenesis of psoriasis. In particular, these antimicrobial peptides enhance the binding of damage-associated molecular patterns such as self-DNA and self-RNA to their receptors and promote the secretion of interferon from activated plasmacytoid dendritic cells and keratinocytes to promote inflammation in psoriasis. Neutrophil extracellular traps (NETs), complexes of self-DNA and proteins including LL-37 released from neutrophils in psoriatic skin, induce Th17. Activated myeloid dendritic cells secrete a mass of inflammatory cytokines such as IL-12 and IL-23 in psoriasis, which is indispensable for the proliferation and survival of T cells that produce IL-17. AMPs enhance the production of some of Th17 and Th1 cytokines and modulate receptors and cellular signaling in psoriasis. Inflammation induced by DAMPs, including self-DNA and RNA released due to microinjuries or scratches, and the enhanced recognition of DAMPs by AMPs, may be involved in the mechanism underlying the Köbner phenomenon in psoriasis.

13 September 2011 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
Toshiya TakahashiToshiya Takahashi
Toshiya Takahashi
YKYutaka Kimura
Yutaka Kimura
RSRumiko Saito
Rumiko Saito
YNYoshihiro Nakajima
Yoshihiro Nakajima
YOYoshihiro Ohmiya
Yoshihiro Ohmiya
SASetsuya Aiba
Setsuya Aiba
Several studies have suggested that interleukin (IL)-8 can serve as a biomarker for discrimination of skin sensitizers from nonsensitizers. We established a stable THP-1–derived IL-8 reporter cell line, THP-G8, which harbors SLO and SLR luciferase genes under the control of IL-8 and glyceraldehyde 3-phosphate dehydrogenase promoters, respectively. After 6 h treatment with chemicals, normalized SLO luciferase activity (nSLO-LA) was calculated by dividing SLO-LA by SLR-LA, and the fold induction of nSLO-LA (FInSLO-LA) was calculated by dividing nSLO-LA of chemically treated cells by that of nontreated cells. The nSLO-LA of THP-G8 cells increased in response to lipopolysaccharide (LPS) and several sensitizers. The FInSLO-LA in THP-G8 cells induced by LPS or sensitizers positively correlated with their induction of IL-8 messenger RNA in THP-1 cells. The nSLO-LA value of THP-G8 cells was significantly increased (FInSLO-LA ≥ 1.4) by 13 of the 15 sensitizers as well as by 5 of the 7 nonsensitizers. Interestingly, pretreatment with N-acetylcysteine suppressed the increase in FInSLO-LA induced by all sensitizers (inhibition index (II) ≤ 0.8) but did not suppress that induced by most of the nonsensitizers. We then evaluated the performance of this assay using values of FInSLO-LA ≥ 1.4 and II ≤ 0.8 in at least two of three independent experiments as the criteria of a sensitizer, which resulted in test accuracies of 82% for the 22 chemicals used and of 88% for the chemicals proposed by European Center for the Validation of Alternative Methods. This newly developed assay is a candidate replacement for animal tests of skin sensitization because of its accuracy, convenience, and high throughput performance.

5 March 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Toshiya TakahashiToshiya Takahashi
Toshiya Takahashi
NKNikhil Nitin Kulkarni
Nikhil Nitin Kulkarni
ELErnest Y Lee
Ernest Y Lee
Lingjuan ZhangLingjuan Zhang
Lingjuan Zhang
GWGerard C. L. Wong
Gerard C. L. Wong
RGRichard L. Gallo
Richard L. Gallo
Under homeostatic conditions the release of self-RNA from dying cells does not promote inflammation. However, following injury or inflammatory skin diseases such as psoriasis and rosacea, expression of the cathelicidin antimicrobial peptide LL37 breaks tolerance to self-nucleic acids and triggers inflammation. Here we report that LL37 enables keratinocytes and macrophages to recognize self-non-coding U1 RNA by facilitating binding to cell surface scavenger receptors that enable recognition by nucleic acid pattern recognition receptors within the cell. The interaction of LL37 with scavenger receptors was confirmed in human psoriatic skin, and the ability of LL37 to stimulate expression of interleukin-6 and interferon-β1 was dependent on a 3-way binding interaction with scavenger receptors and subsequent clathrin-mediated endocytosis. These results demonstrate that the inflammatory activity of LL37 is mediated by a cell-surface-dependent interaction and provides important new insight into mechanisms that drive auto-inflammatory responses in the skin.

29 August 2019 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
NKNikhil N. Kulkarni
Nikhil N. Kulkarni
Toshiya TakahashiToshiya Takahashi
Toshiya Takahashi
JSJames A. Sanford
James A. Sanford
YTYun Tong
Yun Tong
AGAdrian Gombart
Adrian Gombart
RGRichard L. Gallo
Richard L. Gallo

1 January 2017 in Dermatologic Clinics
Verified
Journal Article
Closed access
Toshiya TakahashiToshiya Takahashi
Toshiya Takahashi
RGRichard L. Gallo
Richard L. Gallo

1 October 2015 in Toxicology in Vitro
Verified
Journal Article
Closed access
YKYutaka Kimura
Yutaka Kimura
CFChizu Fujimura
Chizu Fujimura
YIYumiko Ito
Yumiko Ito
Toshiya TakahashiToshiya Takahashi
Toshiya Takahashi
YNYoshihiro Nakajima
Yoshihiro Nakajima
SASetsuya Aiba
Setsuya Aiba